Related references
Note: Only part of the references are listed.A SLC39A8 variant causes manganese deficiency, and glycosylation and mitochondrial disorders
Lisa G. Riley et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
PMM2-CDG and sensorineural hearing loss
Cigdem Seher Kasapkara et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature
D. Marques-da-Silva et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
What is new in CDG?
Jaak Jaeken et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature
D. Marques-da-Silva et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature
Manuel Schiff et al.
JOURNAL OF MEDICAL GENETICS (2017)
Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II
Amal Al Teneiji et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Facial dysmorphism is influenced by ethnic background of the patient and of the evaluator
A. Lumaka et al.
CLINICAL GENETICS (2017)
A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9
Emma Tham et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG
Per Bengtson et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies
Eva Morava et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach
K. Doerre et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
ALG8-CDG: novel patients and review of the literature
Michaela Hoeck et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment
Mercedes Serrano et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Glycobiology of α-dystroglycan and muscular dystrophy
Tamao Endo
JOURNAL OF BIOCHEMISTRY (2015)
Genetic defects in dolichol metabolism
Anna Buczkowska et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation
Rita Barone et al.
JOURNAL OF NEUROLOGY (2015)
ALG11-CDG: Three novel mutations and further characterization of the phenotype
L. Regal et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2015)
29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype
Marie-Lorraine Monin et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Subcutaneous fat pads on body MRI - an early sign of congenital disorder of glycosylation PMM2-CDG (CDG1a)
Almundher A. Al-Maawali et al.
PEDIATRIC RADIOLOGY (2014)
Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
Judith Cossins et al.
BRAIN (2013)
PMM2-CDG: Phenotype and genotype in four affected family members
Barbara Bortot et al.
GENE (2013)
Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG
Dorothy A. Thompson et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Abnormal fat distribution in PMM2-CDG
D. F. G. J. Wolthuis et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Clinical picture of S-adenosylhomocysteine hydrolase deficiency resembles phosphomannomutase 2 deficiency
Tomas Honzik et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Hypertrophic Cardiomyopathy With Cardiac Rupture and Tamponade Caused by Congenital Disorder of Glycosylation Type Ia
Laura I. Rudaks et al.
PEDIATRIC CARDIOLOGY (2012)
Hexosamine Biosynthetic Pathway Mutations Cause Neuromuscular Transmission Defect
Jan Senderek et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip
Nina Rind et al.
HUMAN MOLECULAR GENETICS (2010)
Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis?
Nadia Leticee et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Quality control of glycoproteins bearing truncated glycans in an ALG9-defective (CDG-IL) patient
Wendy Vleugels et al.
GLYCOBIOLOGY (2009)
RFT1 Deficiency in Three Novel CDG Patients
Wendy Vleugels et al.
HUMAN MUTATION (2009)
Congenital disorder of glycosylation type Ia in a Malaysian family: Clinical outcome and description of a novel PMM2 mutation
M. K. Thong et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia)
S. Romano et al.
JOURNAL OF MEDICAL GENETICS (2009)
Clinical phenotype correlates to glycoprotein phenotype in a sib pair with CDG-Ia
Rita Barone et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Congenital disorder of glycosylation type Ia: A non-progressive encephalopathy associated with multisystemic involvement
Jaime Moritz Brum et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2008)
Pericardial and abdominal fluid accumulation in Congenital Disorder of Glycosylation type Ia
Gerben Truin et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening
S. Vermeer et al.
JOURNAL OF NEUROLOGY (2007)
Congenital disorder of glycosylation type Ia presenting with hydrops fetalis
J. M. van de Kamp et al.
JOURNAL OF MEDICAL GENETICS (2007)
Prenatal Diagnosis of congenital disorder of glycosylation type la (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops
Matthew Edwards et al.
PRENATAL DIAGNOSIS (2006)
Congenital disorders of glycosylation type I:: a rare but new cause of hyperechoic kidneys in infants and children due to early microcystic changes
L Hertz-Pannier et al.
PEDIATRIC RADIOLOGY (2006)
Unusual presentation of congenital disorder of glycosylationtype 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema
V Noelle et al.
EUROPEAN JOURNAL OF PEDIATRICS (2005)
Deficiency of UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij
XH Wu et al.
HUMAN MUTATION (2003)
Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins
GM Enns et al.
JOURNAL OF PEDIATRICS (2002)
CDG (congenital disorders of glycosylation) - differential diagnosis of hereditary ataxia in adults
S Bubel et al.
NERVENARZT (2002)
A deletion-insertion mutation in the phosphomannomutase 2 gene in an African American patient with congenital disorders of glycosylation-Ia
N Tayebi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype
S Kjaergaard et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Scandinavian CDG-Ia patients:: genotype/phenotype correlation and geographic origin of founder mutations
A Erlandson et al.
HUMAN GENETICS (2001)
High residual activity of PMM2 in patients' fibroblasts:: Possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency)
S Grünewald et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases
P de Lonlay et al.
JOURNAL OF MEDICAL GENETICS (2001)
Ocular motor signs in an infant with carbohydrate-deficient glycoprotein syndrome type Ia
KL Stark et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2000)
Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1
F Imtiaz et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2000)